<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01261676</url>
  </required_header>
  <id_info>
    <org_study_id>09-4-047</org_study_id>
    <secondary_id>17100.3006</secondary_id>
    <nct_id>NCT01261676</nct_id>
  </id_info>
  <brief_title>Current Dutch Practice on Caesarean Sections: Identification of Barriers and Facilitators for Optimal Care</brief_title>
  <acronym>SIMPLE</acronym>
  <official_title>Current Dutch Practice on Caesarean Sections: Identification of Barriers and Facilitators for Optimal Care.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ZonMw: The Netherlands Organisation for Health Research and Development</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <brief_summary>
    <textblock>
      Caesarean (CS) delivery rates in the Netherlands increased from 5 to 15% the last 20 years.
      CSs have no clear benefit for overall neonatal outcome and are associated with higher
      maternal complications and high costs. Dutch guidelines offer clear recommendations on
      factors that have a direct effect on the decision to perform a CS.

      Hypothesis: there is incomplete adherence to the recommendations from the guidelines on CS
      among Dutch gynaecologists.

      This study consists of four phases:

        1. Development of quality indicators: A set of quality indicators regarding the process,
           structure and outcome of care will be developed according to the RAND-modified Delphi
           method. A representative, national expert panel consisting of 12 to 15 obstetricians and
           midwives will participate.

        2. Current care study: The current Dutch care will be studied in 20 hospitals (N=80
           gynaecologists). 1000 files on performed CSs are analyzed regarding the adherence to the
           developed quality indicators. To get insight into Dutch practices compared to
           international data, basic obstetrical data will be extracted from the delivery database.

        3. Barrier analysis: A barrier analysis will be carried out based on the results of the
           current care study. Two groups of hospitals will be identified in the upper and lower
           extremes of the 'adherence distribution': 5 hospitals with the lowest and 5 hospitals
           with the highest adherence scores. Factors that determine the decision to perform a CS
           or not (barriers and facilitators) will be analyzed in both groups using semi-structured
           interviews among 15-20 professionals and 15-20 patients. A questionnaire will be used to
           study the 'prevalence' of these factors among all obstetric gynaecologists in the
           Netherlands and among 200 patients.

        4. Controlled before- and-after (CBA) study: Based on the outcomes of the current care
           study and the barrier analysis, a tailor made implementation strategy will be developed
           in order to increase adherence to the CS quality indicators. Target groups will be
           selected with focus on women with both a high incidence of the indicator and low
           indicator adherence. The strategy will be executed and evaluated in a CBA-study in 12
           hospitals (6 intervention, 6 control) in terms of effectiveness, experiences and costs.
           The sample size will be dependent on the target group and adherence to the quality
           indicators regarding this target group. These data will be available after performing
           the current care and the barrier study.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>December 2010</start_date>
  <primary_completion_date type="Anticipated">October 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>1) Development of quality indicators: development of a valid set of quality indicators for measuring current Dutch care on caesarean sections</measure>
    <time_frame>December 2010 - October 2013</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>2) Current care study: The main outcome is the adherence to the quality indicators regarding the process, structure and outcome (maternal and fetal) of care</measure>
    <time_frame>December 2010 - October 2013</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>3) Barrier and facilitator analysis: Identification of barriers and facilitators to perform a caesarean section</measure>
    <time_frame>December 2010 - October 2013</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>4) Controlled before-and-after study: effectiveness of the implementation strategy defined as observed increase in adherence between the intervention and control hospitals and actual CS rates in both groups</measure>
    <time_frame>December 2010 - October 2013</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>1) Development of quality indicators: no secondary outcomes</measure>
    <time_frame>December 2010 - October 2013</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>2) Current care study: International comparison</measure>
    <time_frame>December 2010- October 2013</time_frame>
    <description>Dutch practice as compared to international data (Robson criteria)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>3) Barrier and facilitator analysis: no secondary outcomes</measure>
    <time_frame>December 2010-October 2013</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>4) Controlled before-and-after study: experiences and satisfaction of health care providers and patients with the implementation strategy and applicability and costs of the strategy</measure>
    <time_frame>December 2010-October 2013</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Caesarean Section</condition>
  <arm_group>
    <arm_group_label>Caesarean section</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Vaginal birth (control)</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Implementation aids</intervention_name>
    <description>An implementation strategy to improve outcome for women in labour will be developed depending on the outcome of the current care study and the barrier and facilitator analysis.The strategy will be executed and evaluated in a controlled before-and-after study in 12 hospitals (6 intervention, 6 control)</description>
    <arm_group_label>Caesarean section</arm_group_label>
    <arm_group_label>Vaginal birth (control)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        1. Development of quality indicators: 12-15 obstetricians and midwives

          2. Current care study: All women (1000) who underwent a CS in one of the 20 participating
             hospitals during the study period (3-4 months). All hospitals participate in the Dutch
             consortium and consist of university teaching-, non-university teaching- and
             non-university-non-teaching hospitals.

          3. Barrier analysis: Qualitative: 15-20 professionals and 15-20 patients from the
             hospitals in the upper and lower extremes of the 'adherence distribution'.
             Quantitative: obstetricians in the Netherlands and 200 experienced patients.

          4. CBA study: depending on the outcome of phase 2 and 3 of the study, the implementation
             strategy will be designed for a target group with low guideline adherence and high
             incidence.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A previous caesarean section in a 3-4 month time period.

        Exclusion Criteria:

          -  Major congenital malformality

          -  Fetal death prior to onset of delivery

          -  Duration of pregnancy less than 24 weeks of gestation
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hubertina CJ Scheepers, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ziekenhuisgroep Twente</name>
      <address>
        <city>Almelo</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Flevo Ziekenhuis</name>
      <address>
        <city>Almere</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Meander Medisch Centrum</name>
      <address>
        <city>Amersfoort</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Academisch Medisch Centrum</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gelreziekenhuizen</name>
      <address>
        <city>Apeldoorn</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rijnstate Ziekenhuis</name>
      <address>
        <city>Arnhem</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ijsselland Ziekenhuis</name>
      <address>
        <city>Capelle aan den Ijjsel</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Catharina-ziekenhuis</name>
      <address>
        <city>Eindhoven</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Centre Groningen</name>
      <address>
        <city>Groningen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>RÃ¶pcke-Zweers Ziekenhuis</name>
      <address>
        <city>Hardenberg</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Atrium Medisch Centrum Parkstad</name>
      <address>
        <city>Heerlen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Elkerliek Ziekenhuis</name>
      <address>
        <city>Helmond</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tergooiziekenhuizen</name>
      <address>
        <city>Hilversum</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maastricht Universitair Medisch Centrum</name>
      <address>
        <city>Maastricht</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitair Medisch Centrum St. Radboud</name>
      <address>
        <city>Nijmegen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orbis Medisch Centrum</name>
      <address>
        <city>Sittard</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitair Medisch Centrum Utrecht</name>
      <address>
        <city>Utrecht</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maxima Medisch Centrum</name>
      <address>
        <city>Veldhoven</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sint Jansgasthuis</name>
      <address>
        <city>Weert</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zaans Medisch Centrum</name>
      <address>
        <city>Zaandam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <link>
    <url>http://www.studies-obsgyn.nl/simple</url>
  </link>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 15, 2010</study_first_submitted>
  <study_first_submitted_qc>December 15, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 16, 2010</study_first_posted>
  <last_update_submitted>October 29, 2012</last_update_submitted>
  <last_update_submitted_qc>October 29, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 30, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>caesarean section</keyword>
  <keyword>labour, obstetric</keyword>
  <keyword>implementation guidelines</keyword>
  <keyword>quality indicators</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

